腹针治疗肾虚血瘀型膝关节骨性关节炎的临床及实验研究
|
摘要
背景
膝关节骨性关节炎,是一种常见的多发于中年以后的风湿性疾病。国内初步流行病学调查显示,估计有骨性关节炎的病例约5000万以上,其中膝关节占主要部分,已成为影响中老年人健康以及慢性残疾的重要原因之一。现代医学对膝关节骨性关节炎的病因尚不十分明确,近年来,细胞因子与膝关节骨性关节炎的发病成为新的研究热点,其中分解性细胞因子白细胞介素-1(IL-1)和肿瘤坏死因子(TNF)备受关注。中医认为膝关节骨性关节炎属“痹证”、“骨痹”之范畴,在膝关节骨性关节炎防治方面具有一定的优势。腹针是由薄智云教授创立的一种特殊针法,它继承了传统针灸简、便、廉、验的优点,同时发展了中医“神阙布气”学院。对膝关节骨性关节炎的治疗收到了满意的疗效。随着对腹针的应用实现了辨证条理化、处方标准化、操作规范化,为腹针的科研研究提供了一个很好的平台。
目的
本研究在系统回顾及研究骨性关节炎现代中西医文献、及古代中医文献的基础上,通过随机对照的临床实验研究,来验证腹针疗法对肾虚血瘀型膝关节骨性关节炎的临床疗效。同时,通过随机对照的动物实验,观察腹针疗法对膝关节骨性关节炎动物模型血清肿瘤坏死因子a (TNF-α)及白细胞介素-1(IL-1)水平的影响,从而在分子生物学水平上,探讨腹针疗法的作用机理及靶点,最终为腹针疗法的进一步推广提供可靠的临床依据及实验基础。
方法
临床研究部分：对符合纳入条件的150名广东省中医院门诊膝关节骨性关节炎患者,以简单随机的方法将其分为实验组及对照组。对照组予以基础治疗3月(口服盐酸氨基葡萄糖胶囊,0.48/次,3次/日),实验组予以基础治疗+腹针治疗3月。分别在治疗前后及治疗后1月、2月以视觉模拟疼痛评分法(Visual Analogue Scale/Score,简称VAS)及HSS量表进行疼痛及膝关节功能评分,并分析其差异性。同时参照《中药新药临床研究指导原则》中的疾病疗效判定标准及证候疗效判定标准,来评价两组的治疗效果及其差异性。
实验研究部分：采用Hulth造模法,建立膝关节骨性关节炎家兔模型共20只,以简单随机的方法将其分为实验组15只,对照组5只。实验组予以腹针治疗,每3天一次,共10次。对照组予以自由喂养,不做任何治疗。分别于造模前后,及治疗后于兔耳缘静脉抽取静脉全血,以EILSA定量法测出血清肿瘤坏死因子α(TNF-α)及白细胞介素-1(IL-1)的含量,并分析其差异性。
结果
临床研究部分：150名受试者中,中途失访者23名,未能坚持疗程者7名,最终有120名患者完成实验研究,其中实验组68例,对照组52例；两组间性别构成、年龄分布、发病部位、病程、VAS评分、HSS评分及X光Kellgren-Lawrence分级比较无差异性,说明两组间一般情况均衡,具有可比性。实验组与对照组HSS评分均值与X光Kellgren-Lawrence分级呈负相关,即X光分级越高,HSS评分均值越低。实验组与对照组VAS均值与X光Kellgren-Lawrence分级呈正相关,即X光分级越高,VAS均值越高。
实验组、对照组各组治疗前后比较,P<0.01,差异非常显著,说明实验组及对照组均有效；治疗后,实验组与治疗组比较,P<0.01,差异非常显著,说明实验组的疗效优于对照组；治疗后1月后,实验组与对照组比较,P<0.05,差异显著,说明实验组疗效较治疗后减弱,但仍优于对照组；治疗后2月,实验组与对照组比较,P>0.05,无统计学意义,说明实验组与对照组疗效无差异性。
实验组与对照组疾病疗效评定,两组总有效率比较,P<0.05,差异显著,说明实验组疗效优于对照组。实验组与对照组证候疗效评定,两组总有效率比较,P<0.01,差异非常显著,说明实验组疗效优于对照组。
实验研究部分：采用Hulth造模法,在4周后通过电镜观察软骨标本,证实获得满意的膝关节骨性关节炎动物模型。实验组与对照组治疗前,两组动物在体重及血清TNF-α、IL-1含量比较,P>0.05,无统计学意义,说明两组间一般情况均衡,具有可比性。造模后与造模前血清TNF-α及IL-1含量比较,实验组和对照组均升高,P<0.05,差异显著,说明骨性关节炎动物模型血清TNF-α及IL-1含量高于正常；实验组治疗后血清TNF-α及IL-1含量比较,治疗后低于治疗前,P<0.05,差异显著,说明实验组治疗后血清TNF-α及IL-1含量下降；对照组治疗前后血清TNF-α及IL-1含量比较,治疗后高于治疗前,P<0.05,差异显著,说明对照组1月后血清TNF-α及IL-1含量上升。
结论
通过本项研究,可得出如下结论：1.腹针为一种新的针灸疗法,其治疗膝关节骨性关节炎的处方具有扶正固本、祛风除湿、化瘀通络的作用,经临床研究证实,其治疗效果确切,值得进一步推广。但同时研究发现其作用具有一定的时效性。2.膝关节骨性关节炎的临床辩证以肾虚血瘀型为主,其中肾虚为本,血瘀为标,肾虚血瘀型为本病证型变化之基础。3.腹针治疗后可以降低膝关节骨性关节炎模型动物血清的肿瘤坏死因子α及白细胞介素-1水平,从而保护关节软骨,改善骨性关节炎患者的症状,这可能是腹针治疗膝关节骨性关节炎的作用机理或靶点之一。4.中医治疗膝关节骨性关节炎临床疗效研究中,可根据具体的研究目标,选用HSS评分加《中药新药临床研究指导原则》中的疾病疗效判定标准及证候疗效判定标准,以及VAS和HSS评分表中的一项为宜。同时可设立单独一组科研人员来进行临床疗效的观察,以防止出现偏差。5.细胞因子与膝关节骨性关节炎的发生关系密切,血清肿瘤坏死因子α及白细胞介素-1的水平与软骨的破坏呈正相关。6Hulth造模法,4周后即可获得稳定的动物模型,若要对中、晚期骨性关节炎进行研究,可以适当延长造模时间。7.膝关节骨性关节炎患者的临床症状、体征,与影像学Kellgren-Lawrence分级呈正相关。
Objectives
Based on the systematic review in both the literature of modern integrated Chinese & Western medicine and ancient literature about osteoarthritis, the randomly controlled clinical trials research was conducted to investigate the clinical effect of abdominal acupuncture on knee osteoarthritis defined by Deficiency of Kidney and Blood stasis. The randomized controlled animal experiment was also carried out to examine the effect of abdominal acupuncture on the production of serum tumor necrosis factorα(TNF-α) and Interleukin-1 (IL-1) contents in rabbits with knee osteoarthritis, and to investigate the mechanism and target of abdominal acupuncture at the molecular levels. The study enhanced the reliable clinical evidence and experimental basis and further promote abdominal acupuncture into the practice。
Methods
150 individuals with knee osteoarthritis who met the inclusive criteria from the Guangdong Hospital of Traditional Chinese Medicine, were randomly divided into treated group and control group. The control group were treated with the primary treatment for 3 months (Glucosamine hydrochloride, P0.0.48, tid), The treated group received both the primary treatment and abdominal acupuncture for 3 months. Respectively, we scored the pain and knee function prior and post to treatment according to Visual Analogue Scale (VAS) and the HSS scale, and analyzed their therapeutic effect and differences according to Guiding Principles of new drug clinical research of Chinese medicine.
20 rabbits with knee osteoarthritis were generated according to Hulth procedure,15 into experimental group with treatment of abdominal acupuncture (once every 3 days, a total of 10 times),5 was into control group with regular feeding without treatment. Venous blood was collected via ear vein pricr and post to treatment, TNF-αand IL-1 contents detected with EILSA and compared.
Results
Among 150 individuals,23 failed to be followed-up,7 were unable to adhere to treatment, the rest of 120 individuals completed the final test,68 of them were in experimental group,52 in control group. Between the two groups, the gender, age, location, course, VAS score, HSS score and X-ray Kellgren-Lawrence grade showed no significant difference, indicating the identification in general condition. The average HSS scores in the two groups were negatively correlated with X-ray Kellgren-Lawrence grade, that is, the higher the X-ray classification, the lower the HSS scores; however, the average VAS scores were positively correlated with X-ray Kellgren-Lawrence grade, the higher the X-ray classification, the higher the VAS scores.
Prior and post to treatment, it showed significant differences between groups, P<0.01, indicating that the treatment was valid in the two groups; after the treatment, the experimental group and control group showed significant differences, P<0.01, indicating that the treatment was more effective in experimental group than in control group; one month later after treatment, it showed differences between groups, P<0.05, indicating that the treatment efficacy in experimental group become weaker, though it still better than control group; two months after treatment, it showed no statistically significant differences, P>0.05, indicating there was no difference in the two groups.
Evaluation of the therapeutic efficacy between groups showed the significant differences in effective rate, P<0.05, indicating the efficacy in experimental group was better than control group. While the evaluation of syndromes showed stronger significant differences in the rate, P<0.01, indicating the treatment efficacy in experimental group was still better than control group.
By Hulth method, animal model of knee osteoarthritis was generated after 4 weeks. Prior and post to treatment, there was no differences in the body weight, serum TNF-α, IL-1 contents between experimental group and control group, P>0.05, indicating identification in general condition. Prior and post to model establishment, the contents of serum TNF-α, IL-1 in both experimental group and control group showed statistics differences, P<0.05, indicating it was higher in animal models than control ones. Before and after treatment, the contents of serum TNF-α, IL-1 in experimental group showed statistics differences, P<0.05, indicating that treatment made it decline. Before and after treatment, the contents of serum TNF-α, IL-1 in control group showed statistics differences, P<0.05, indicating that treatment had the effect.
Conclusions
It was concluded in this study that 1. Abdominal acupuncture needle as a new therapy, proven by clinical studies, is effective in the treatment of knee osteoarthritis, so it is worth promoting, although certain timeliness.2. The clinical dialectical, the syndrome types changes foundation of the knee osteoarthritis is deficiency of Kidney and Blood stasis, between them deficiency of kidney is the root while blood stasis is the branch.3. The study confirms that abdominal acupuncture can reduce the TNF-α, IL-1 contents in animal model of knee osteoarthritis, thus protect the articular cartilage and improve symptoms of osteoarthritis.4. Cytokines is closely related to the incidence of knee osteoarthritis, among them the serum tumor necrosis factor a and interleukin-1 contents is positively correlated with the destruction of cartilage.5. By Hulth method, animal model of knee osteoarthritis was produced after 4 weeks, but to middle and late osteoarthritis, modeling time can be extended.6. Abdominal acupuncture has a positive impact on the regulation of cartilage by cytokine, which may be one of the mechanism or target about abdominal acupuncture for knee osteoarthritis.7. The symptoms and signs in patients with knee osteoarthritis have a positive correlation with the radiological Kellgren-Lawrence grade.
膝关节骨性关节炎,是一种常见的多发于中年以后的风湿性疾病。国内初步流行病学调查显示,估计有骨性关节炎的病例约5000万以上,其中膝关节占主要部分,已成为影响中老年人健康以及慢性残疾的重要原因之一。现代医学对膝关节骨性关节炎的病因尚不十分明确,近年来,细胞因子与膝关节骨性关节炎的发病成为新的研究热点,其中分解性细胞因子白细胞介素-1(IL-1)和肿瘤坏死因子(TNF)备受关注。中医认为膝关节骨性关节炎属“痹证”、“骨痹”之范畴,在膝关节骨性关节炎防治方面具有一定的优势。腹针是由薄智云教授创立的一种特殊针法,它继承了传统针灸简、便、廉、验的优点,同时发展了中医“神阙布气”学院。对膝关节骨性关节炎的治疗收到了满意的疗效。随着对腹针的应用实现了辨证条理化、处方标准化、操作规范化,为腹针的科研研究提供了一个很好的平台。
目的
本研究在系统回顾及研究骨性关节炎现代中西医文献、及古代中医文献的基础上,通过随机对照的临床实验研究,来验证腹针疗法对肾虚血瘀型膝关节骨性关节炎的临床疗效。同时,通过随机对照的动物实验,观察腹针疗法对膝关节骨性关节炎动物模型血清肿瘤坏死因子a (TNF-α)及白细胞介素-1(IL-1)水平的影响,从而在分子生物学水平上,探讨腹针疗法的作用机理及靶点,最终为腹针疗法的进一步推广提供可靠的临床依据及实验基础。
方法
临床研究部分：对符合纳入条件的150名广东省中医院门诊膝关节骨性关节炎患者,以简单随机的方法将其分为实验组及对照组。对照组予以基础治疗3月(口服盐酸氨基葡萄糖胶囊,0.48/次,3次/日),实验组予以基础治疗+腹针治疗3月。分别在治疗前后及治疗后1月、2月以视觉模拟疼痛评分法(Visual Analogue Scale/Score,简称VAS)及HSS量表进行疼痛及膝关节功能评分,并分析其差异性。同时参照《中药新药临床研究指导原则》中的疾病疗效判定标准及证候疗效判定标准,来评价两组的治疗效果及其差异性。
实验研究部分：采用Hulth造模法,建立膝关节骨性关节炎家兔模型共20只,以简单随机的方法将其分为实验组15只,对照组5只。实验组予以腹针治疗,每3天一次,共10次。对照组予以自由喂养,不做任何治疗。分别于造模前后,及治疗后于兔耳缘静脉抽取静脉全血,以EILSA定量法测出血清肿瘤坏死因子α(TNF-α)及白细胞介素-1(IL-1)的含量,并分析其差异性。
结果
临床研究部分：150名受试者中,中途失访者23名,未能坚持疗程者7名,最终有120名患者完成实验研究,其中实验组68例,对照组52例；两组间性别构成、年龄分布、发病部位、病程、VAS评分、HSS评分及X光Kellgren-Lawrence分级比较无差异性,说明两组间一般情况均衡,具有可比性。实验组与对照组HSS评分均值与X光Kellgren-Lawrence分级呈负相关,即X光分级越高,HSS评分均值越低。实验组与对照组VAS均值与X光Kellgren-Lawrence分级呈正相关,即X光分级越高,VAS均值越高。
实验组、对照组各组治疗前后比较,P<0.01,差异非常显著,说明实验组及对照组均有效；治疗后,实验组与治疗组比较,P<0.01,差异非常显著,说明实验组的疗效优于对照组；治疗后1月后,实验组与对照组比较,P<0.05,差异显著,说明实验组疗效较治疗后减弱,但仍优于对照组；治疗后2月,实验组与对照组比较,P>0.05,无统计学意义,说明实验组与对照组疗效无差异性。
实验组与对照组疾病疗效评定,两组总有效率比较,P<0.05,差异显著,说明实验组疗效优于对照组。实验组与对照组证候疗效评定,两组总有效率比较,P<0.01,差异非常显著,说明实验组疗效优于对照组。
实验研究部分：采用Hulth造模法,在4周后通过电镜观察软骨标本,证实获得满意的膝关节骨性关节炎动物模型。实验组与对照组治疗前,两组动物在体重及血清TNF-α、IL-1含量比较,P>0.05,无统计学意义,说明两组间一般情况均衡,具有可比性。造模后与造模前血清TNF-α及IL-1含量比较,实验组和对照组均升高,P<0.05,差异显著,说明骨性关节炎动物模型血清TNF-α及IL-1含量高于正常；实验组治疗后血清TNF-α及IL-1含量比较,治疗后低于治疗前,P<0.05,差异显著,说明实验组治疗后血清TNF-α及IL-1含量下降；对照组治疗前后血清TNF-α及IL-1含量比较,治疗后高于治疗前,P<0.05,差异显著,说明对照组1月后血清TNF-α及IL-1含量上升。
结论
通过本项研究,可得出如下结论：1.腹针为一种新的针灸疗法,其治疗膝关节骨性关节炎的处方具有扶正固本、祛风除湿、化瘀通络的作用,经临床研究证实,其治疗效果确切,值得进一步推广。但同时研究发现其作用具有一定的时效性。2.膝关节骨性关节炎的临床辩证以肾虚血瘀型为主,其中肾虚为本,血瘀为标,肾虚血瘀型为本病证型变化之基础。3.腹针治疗后可以降低膝关节骨性关节炎模型动物血清的肿瘤坏死因子α及白细胞介素-1水平,从而保护关节软骨,改善骨性关节炎患者的症状,这可能是腹针治疗膝关节骨性关节炎的作用机理或靶点之一。4.中医治疗膝关节骨性关节炎临床疗效研究中,可根据具体的研究目标,选用HSS评分加《中药新药临床研究指导原则》中的疾病疗效判定标准及证候疗效判定标准,以及VAS和HSS评分表中的一项为宜。同时可设立单独一组科研人员来进行临床疗效的观察,以防止出现偏差。5.细胞因子与膝关节骨性关节炎的发生关系密切,血清肿瘤坏死因子α及白细胞介素-1的水平与软骨的破坏呈正相关。6Hulth造模法,4周后即可获得稳定的动物模型,若要对中、晚期骨性关节炎进行研究,可以适当延长造模时间。7.膝关节骨性关节炎患者的临床症状、体征,与影像学Kellgren-Lawrence分级呈正相关。
Objectives
Based on the systematic review in both the literature of modern integrated Chinese & Western medicine and ancient literature about osteoarthritis, the randomly controlled clinical trials research was conducted to investigate the clinical effect of abdominal acupuncture on knee osteoarthritis defined by Deficiency of Kidney and Blood stasis. The randomized controlled animal experiment was also carried out to examine the effect of abdominal acupuncture on the production of serum tumor necrosis factorα(TNF-α) and Interleukin-1 (IL-1) contents in rabbits with knee osteoarthritis, and to investigate the mechanism and target of abdominal acupuncture at the molecular levels. The study enhanced the reliable clinical evidence and experimental basis and further promote abdominal acupuncture into the practice。
Methods
150 individuals with knee osteoarthritis who met the inclusive criteria from the Guangdong Hospital of Traditional Chinese Medicine, were randomly divided into treated group and control group. The control group were treated with the primary treatment for 3 months (Glucosamine hydrochloride, P0.0.48, tid), The treated group received both the primary treatment and abdominal acupuncture for 3 months. Respectively, we scored the pain and knee function prior and post to treatment according to Visual Analogue Scale (VAS) and the HSS scale, and analyzed their therapeutic effect and differences according to Guiding Principles of new drug clinical research of Chinese medicine.
20 rabbits with knee osteoarthritis were generated according to Hulth procedure,15 into experimental group with treatment of abdominal acupuncture (once every 3 days, a total of 10 times),5 was into control group with regular feeding without treatment. Venous blood was collected via ear vein pricr and post to treatment, TNF-αand IL-1 contents detected with EILSA and compared.
Results
Among 150 individuals,23 failed to be followed-up,7 were unable to adhere to treatment, the rest of 120 individuals completed the final test,68 of them were in experimental group,52 in control group. Between the two groups, the gender, age, location, course, VAS score, HSS score and X-ray Kellgren-Lawrence grade showed no significant difference, indicating the identification in general condition. The average HSS scores in the two groups were negatively correlated with X-ray Kellgren-Lawrence grade, that is, the higher the X-ray classification, the lower the HSS scores; however, the average VAS scores were positively correlated with X-ray Kellgren-Lawrence grade, the higher the X-ray classification, the higher the VAS scores.
Prior and post to treatment, it showed significant differences between groups, P<0.01, indicating that the treatment was valid in the two groups; after the treatment, the experimental group and control group showed significant differences, P<0.01, indicating that the treatment was more effective in experimental group than in control group; one month later after treatment, it showed differences between groups, P<0.05, indicating that the treatment efficacy in experimental group become weaker, though it still better than control group; two months after treatment, it showed no statistically significant differences, P>0.05, indicating there was no difference in the two groups.
Evaluation of the therapeutic efficacy between groups showed the significant differences in effective rate, P<0.05, indicating the efficacy in experimental group was better than control group. While the evaluation of syndromes showed stronger significant differences in the rate, P<0.01, indicating the treatment efficacy in experimental group was still better than control group.
By Hulth method, animal model of knee osteoarthritis was generated after 4 weeks. Prior and post to treatment, there was no differences in the body weight, serum TNF-α, IL-1 contents between experimental group and control group, P>0.05, indicating identification in general condition. Prior and post to model establishment, the contents of serum TNF-α, IL-1 in both experimental group and control group showed statistics differences, P<0.05, indicating it was higher in animal models than control ones. Before and after treatment, the contents of serum TNF-α, IL-1 in experimental group showed statistics differences, P<0.05, indicating that treatment made it decline. Before and after treatment, the contents of serum TNF-α, IL-1 in control group showed statistics differences, P<0.05, indicating that treatment had the effect.
Conclusions
It was concluded in this study that 1. Abdominal acupuncture needle as a new therapy, proven by clinical studies, is effective in the treatment of knee osteoarthritis, so it is worth promoting, although certain timeliness.2. The clinical dialectical, the syndrome types changes foundation of the knee osteoarthritis is deficiency of Kidney and Blood stasis, between them deficiency of kidney is the root while blood stasis is the branch.3. The study confirms that abdominal acupuncture can reduce the TNF-α, IL-1 contents in animal model of knee osteoarthritis, thus protect the articular cartilage and improve symptoms of osteoarthritis.4. Cytokines is closely related to the incidence of knee osteoarthritis, among them the serum tumor necrosis factor a and interleukin-1 contents is positively correlated with the destruction of cartilage.5. By Hulth method, animal model of knee osteoarthritis was produced after 4 weeks, but to middle and late osteoarthritis, modeling time can be extended.6. Abdominal acupuncture has a positive impact on the regulation of cartilage by cytokine, which may be one of the mechanism or target about abdominal acupuncture for knee osteoarthritis.7. The symptoms and signs in patients with knee osteoarthritis have a positive correlation with the radiological Kellgren-Lawrence grade.
引文
[1]孙瑛.实用关节炎诊断治疗学[M],北京：人民出版社.2002：319-333.
[2]徐卫东,吴岳嵩,张春才.骨关节炎的诊断与治疗.第二军医大学出版社.
[3]张乃峥,施全胜,张雪哲,等.膝骨关节炎的流行病学调查[J].中华内科杂志.1995：34(2)：84-87.
[4]曾庆徐,黄小粥,陈韧,等.汕头地区风湿病流行病学调查十年小结[J].汕头大学医学院学报.1997：10(2)：59-63.
[5]张乃峥,曾庆徐,张风山,等.中国风湿性疾病流行情况的调查研究[J]中华风湿病学杂志.1997：1(1)：31-35.
[6]钱颐,孙凌云,王祝新,等.南京郊区农民症状性骨关节炎的流行病学调查明[J].江苏医药杂志2000：26(12)：967-968.
[7]臧长海,曾庆馀,李小峰,等.太原地区骨性关节炎流行病学研究[J].山西医药杂志,2006,35(9)：767-770.
[8]李宁华,张耀南,张毅,等.中国中老年人群手骨性关节炎患病危险因素地区比较分析[J].实用医学杂志,2006,22(13)：1575-1577.
[9]Sakeba N, Issa and Leena Sharma, et al. Epidemiology of osteoarthritis:An update[J]. Current Rheumatology Reports,2006.8(2):7-15.
[10]Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study[J]. Am J Public Health,1994;84:351-358.
[11]邱贵兴.骨性关炎流行病学和病因学新进展[J].继续医学教育,2005,19(7)：68-69.
[12]高仰贤,江蓉星.骨性关节炎发病机制的国内研究进展[J].中医正骨,2005,17(4)：55-57.
[13]Gabriel SE, Cmwson CS, OfaUon wM. The epidemiology of rheumatold arthritis in Rochester, Mirmesom,19S5—1985[J]. ArthritisRheum,1999,42(3): 415-420. Oliveria SA, CafreyM, Linden SM, etal. The anals of epidemiology about human arthritis[J], Epidemiology,2004,15:326-331.
[14]黄涛.骨性关节炎病因和发病机制研究进展[J].福建中医药,2005,36(4)：57.
[15]Grazio S, Balen D. Obesity:risk factor and predictor of osteoarthritis [J]. Ann Intern Med,2009;109:18-24.
[16]Bijlsma JW, Knahr K. Strategies for the prevention and management of osteoarthritis of the hip and knee[J]. Best Pract Res Clin Rheumatol, 2007;21(1):59-76.
[17]Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framing—ham study[J]. Ann Intern Med,1992;116(7):535-539
[18]牛维.软骨下骨在骨性关节炎发病中的作用研究[J].国际骨科学杂志,2006,27(3)：132-13.
[19]Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis [J]. Curr Opin Rheumatol,1998;10:269-272.
[20]Slemenda C, Heilman DK, Brandt KD, et al. Reduced quadriceps strength relative to body weight:a risk factor for knee osteoarthritis in womens [J] Arthritis Rheum,1998:41:1951-1959.
[21]Slemenda C, Brandt KD, Heilman D, et al. Quadriceps weakness and osteoarthritis of the knee[J]. Ann Intern Med,1997;127:97-104.
[22]关拮,卫四来.骨性关节炎病因探讨[J].吉林中医药,2009,29(3)：198-199.
[23]Apparailly F Verwaerde C, Jacquet C, etal. Adenovirus mediatedtransfer of viral IL.10 gene inhibits murine collagen. induced arthfi—tm[J]. J Immunol,1998,160(11):5213-5220.
[24]Raimund w Kinne, Thomas Liehr, Volkmar Beensen. et al. Mosaicchromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthfiti, osteoarthritis and other inflammatory joint disease[J]. Arthritis Res, 2001,3(5):319-330.
[25]王卫国,娄思权,余华,等.TGF-β2转染关节软骨细胞的实验研究[J].中华骨科杂志,2003,23：434.
[26]王玉泉,守敏,柴举龙.蛋白多糖与骨性关节炎的研究[J].中医正骨,2005,17(4)：60.
[27]栗占国.骨性关节炎的发病机制[J].中华全科医师杂志,2003.6(3)：50-51.
[28]Loeser RF. Aging and osteoarthritis:the role of chondrocyte senescence and aging changes in the cartilage matrix [J]. Osteoarthritis Cartilage, 2009 Mar 12. [Epub ahead of print].
[29]Price JS, Waters JG, Darrah C, et al. The role of chondrocyte senescence in osteoarthritis [J]. Aging Cell.2002.1 (1):57-65.
[30]Radin EL, Paul IL. Does cartilage compliance reduce skeletal impact loads? The relative force-attenuating properties of articular cartilage, synovial fluid, periarticular soft tissues and bone. Arthritis Rheum, 1970:13:139-144.
[31]娄思权.软骨修复和重建基础研究的现状.当代医学,2001,735.
[32]Pfander D, Heinz N, Rothe P, et al. Ann Rhenm Dis,2004; 63(3):240-244.
[33]Gebauer M, Saas J, Haag J, et al. Arthritis Res mler,2005; 7(2):R274-R284.
[34]Fan Z, Bau B, Yang H, et al. Arthritis Rheum,2005; 52(1):136-143.
[35]Chevalier X, Giraudeau B. Conrozier T, et al. J Rh eumatl,2005; 32(7): 1317-1323.
[36]田华,娄思权,党耕町等.肿瘤坏死因子-a导致软骨损伤的机制探讨.中华外科杂志.2000,38：76.
[37]程爱新,韩文玲,马大龙等.趋化素样因子1(CKLF1)对关节软骨细胞增殖及代谢的影响.北京大学学报(医学版),2003,35：399.
[38]Barrey Halliwell. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis,1995; 54:505-510.
[39]Little CB, Flannery CR, Hughes CE, et al. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration [J]. Osteoarthritis and Cartilage,2005,13(2):162-170.
[40]田华,党耕町,娄思权等.基质金属蛋白酶及其抑制剂在软骨细胞中的表达及其意义[J].北京医科大学学报,1999：31：189.
[41]郭常安,陈峥蝾,张秀荣.骨性关节炎基质金属蛋白酶1、2、3及其抑制物的表达与软骨退变的关系[J].复旦学报(医学版),2002;29：244.
[42]何永清.骨内高压与退行性膝关节病关系的临床研究[J].中国骨伤,1999,11(6)：3-4.
[43]Amoldi cc, Lemperg ILK, Linderbolm H. Intraosscous hypertension and paininthekne[J], J Bone Joint SurgBr.1975,57(3):360.
[44]许学猛,王羽丰,邓晋丰,等.补肾活血胶囊影响兔膝关节退变性疾病骨内压变化的实验研究[J].中国中医骨伤科杂志,2001,91(4)：24.
[45]毛宾尧,刘洪涛.胫、股骨内压与膝关节疼痛关系的研究和治疗方法探讨[J].骨与关节损伤杂志,1992;7(4)：206.
[46]金伟,陈廖斌.生物自由基与骨性关节炎[J].湖北预防医学杂志,2002;13：13
[47]孙材江,王惠,杨锡兰,等.退行性膝关节炎患者氧自由基代谢的观察.中华骨科杂志,1992：12(6)：433-435.
[48]Bukhardt H Schwingel M Mcmninter H et al Oxgen cadicals as effectors of cartilage destruction Arthritis Rheum 1086(89).379.
[49]李松,曹峻岭.自由基对体外培养人胚关节软骨细胞的影响.中华骨科杂志, 1998：18(7)：426-428.
[50]刘淑芳,李莹辉,徐团才.骨性关节炎的生化及病理变化.中国临床康复,2004：8(5)：938-939.
[51]Johnston SA, Fox SM. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. J Am Vet Med Assoc.1997 15;210(10):1486-92.
[52]高春阳.一氧化氮在骨性关节炎发病机制中的作用.国外医学免疫学分册,2001,24(3)：159.
[53]Pelletier JP. Pathophysiological targets in OA therapy [J]. osteoarthritis Cartilage,1999.7(3):353-4.
[54]Blanco FJ, Lotz M. IL-1 induced nitric oxideide inhibits chondrocyte proliferation via PEGZ, Exp Cell Res,1995,318:31.
[55]Hauselmann HJ, Evans CH, Michel BA,et al. Differencesin nitricoxide product by superficial and deep human articular chondrocyte s:implications for proteogly canturnoxer in inflammatory joint diseased. Jimmunol,1998,160:1444.
[56]Cao M, Westerhausen-Larson A, Niyibizi C, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. [J]. Biochem J,1997,324:305-310.
[57]Heraud F, Heraud A, Harmand M F. Apoptosis in normal and Osteoarthritic human artlcular cartilage. Ann Rheum Dis,2000,59:959.
[58]蔡伟平,汤亭亭骨关节炎的细胞生物学研究进展.国外医学.骨科分册,2004,25：18.
[59]程爱新,王莺,马大龙等.程序化死亡基因5 (PDCD5)在骨关节炎软骨细胞中的表达及意义.北京大学学报(医学版),2003,35：481.
[60]Aixin Cheng, Siquan Lou. Haowei Zhou. et al. Expression of PDCD5, a novel apoptosis related protein, in human osteoarthritic cartilage. Acta Pharrnacol Sin,2004,25:685.
[61]Mazzuca SA, Brandt KD, Katz BPC, et al. Effeccts of self-care education on the health status of inner-city patients with osteoarthritis of the knee. Arthritis rheum,1997;40:1446-1474.
[62]Felson DT, Anderson JJ, Naimark A, et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med,1998:109:18-24.
[63]野战涛,张卫平.关节骨性关节炎的治疗进展.临床误诊误治,2010,3(8)：783-786.
[64]陈景藻.现代物理治疗学.北京：人民军医出版社,2001.
[65]李晶,顾新,李艳,等.老年病物理治疗的经验和体会.中华理疗杂志,1999：22：218-220.
[66]Thamsborg G, Florescu A, Oturai P, et al. Treatment of knee osteoarthritis with pulsed electromagnetic fields:randomized, double-blind, placebo-controlled study [J]. Osteoarthritis-Cartilage,2005,13(7):575-581.
[67]Brandt KD, Bradley JD Should the initial drug used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug[J]. J Rheumatol,2001.28: 467-473
[68]Courtney P, Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthriltis[J]. Ann Rheum Dis,2002,61(9):767-773.
[69]Bombardier C, Laine L, Reiein A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis [J]. N Engl J Med,2000,343(21):1520-1528.
[70]崔长胜.玻璃酸钠关节腔内注射治疗骨关节炎的疗效观察[J].吉林医学,2008.17(29)：1460.
[71]李海萍,王秀敏,吴祖军,等.注射用玻璃酸钠治疗膝关节骨性关节炎[J].中国实用医药,2008,25(3)：101.
[72]张敬中,张维斌,任国忠,等.膝骨性关节炎关节内药物注射的疗效比较[J].辽宁中医药大学学报,2008：9：116-117.
[73]McCarty M F, Russell A L, Seed M P. Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis[J]. Med Hypotheses 2000,54(5):798-802.
[74]Omata T, Itokazu Y, Inoue N, et al. Effects of chondroitinsulfate-C on articular cartilage destruction in murine collagen induced arthritis [J]. ArznejmjttelfOrschung,2000,50(2):148-153.
[75]Monfort J, Nacher M, Montell E, et al. Chondroitin sulfate and hyaluronic acid (500-730 kda) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes[J]. Drugs Exp Clin Res,2005,31(2):71-76.
[76]芮云峰,张晓玲,王友.骨关节炎治疗相关基因研究进展[J].国际骨科学杂志,2007,28(2)：77-80.
[77]Chevalier X, Giraudeau B, Conrozier T, et al. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis:a multicenter study[J]. J Rheumatol,2005,32(7): 1317-1323.
[78]Chevalier X, Goupille P, Beaulieu A D, et al. Intraarticular injection of anakinra in osteoarthritis of the knee:Amulticenter, randomized, double-blind, placebo-controlled study[J]. Arthritis Rheum,2009,61(3): 344-352
[79]JACKSON J P. Osteotomy for arthritis of the knee[J]. J Bone andjoint Surg(Br),1958,40:826-836.
[80]Insall JN, Joseph DM, Msika C. Hi gh tibial osteotomy for varus gonarthrosis. A long-term follow-up study [J]. J Bone Joint Surg Am,1984, 66(7):1040-1048.
[81]曹立峰,裴宪武,李延明,等.改良胫骨高位截骨术治疗膝骨性关节炎32例报告[J].北京医学,2008,30(3)：187-188.
[82]张光铂,曹永廉,李子荣.胫骨高位截骨术的远期疗效[J].中国骨科杂志,1997,17(12)：737-739.
[83]余文君.胫骨高位钻孔减压后推拿治疗膝关节骨性关节病32例.广西中医药,2001：(2)：009.
[84]林志雄,余楠生,卢伟杰.关节镜诊断和治疗膝关节骨关节炎[J].中华骨科杂志,1998,18(4)：199-202.
[85]张卫平,刘长安,钱宇航,等.膝关节镜下治疗髌股关节退行性变的方法探讨[J].中国矫形外科杂志,2004,12(12)：28-29.
[86]Moseley J B,0 Malley K, Petersen N J, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee[J]. N Engl J Med, 2002,347(2):81-88.
[87]Kirkley A, Birmingham T B, Litchfield R B, et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee[J]. N Engl J Med, 2008,359(11):1097-1107.
[88]赵炬才,罗建平,郑稼.带血管蒂筋膜移植修复膝关节软骨大面积缺损.中华骨科杂志,1996：16：479.
[89]Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage,2002, 10 (3):199-206.
[90]Petrou G, Petrou H, Tilkeridis C, et al. Medium-term results with a primary cemented rotating-hinge total knee replacement. A 7 to 15-year follow-up. J Bone Joint Surg Br.2004,86(6):813-817.
[91]Berger RA, Meneghini RM, Jacobs JJ, et al. Results of unicOmpartmental knee arthroplasty at a minimum of ten years of follow-up. J Bone Joint Surg Am,2005,87(5):999-1006.
[92]Callaghan JJ,0'Rourke MR, Johnston RC. The uni experience:history tells it all. Orthopedics,2005,28(9):988.
[93]Squire MW, Callaghan JJ, Goetz DD, et al. Unicompartmental knee replacement. A minimum 15 year follow up study. Clin Orthop Relat Res, 1999(367):61-72.
[94]Newman J, Pydisetty RV, Ackroyd C. Unicompartmental or total knee replacement:the 15-year results of a prospective randomized controlled trail. J Bone J Joint Br,2009,91(1):52-57.
[95]Riddle DL, J iranekWA, McGlynn FJ. Yearly incidence of unieompartmental knee arthroplasty in the United States. J Arthroplasty,2008,23(3): 408-412.
[96]甘煜东,丁晶,徐永清等.膝关节单髁置换的近期疗效观察.中国骨与关节外科,2010,3(4)：291-295.
[97]Murray JR, Birdsall PD, Sher JL, et al. Deprivation and outcome oftotal knee replacement[J]. Knee,2006,13(2):98-101.
[98]赵钟文.从补肾人手缓解膝关节骨性关节炎疼痛60例疗效观察[J].云南中医中药杂志,2005,26(6)：10.
[99]季守贤,包洪,康英.补肾壮骨汤治疗膝关节骨性关节炎42例[J].四川中医,2005,23(12)：82.
[100]薄智云主编.腹针疗法.北京,中国科学技术出版社,2004.129-130
[101]葛鸿庆,陈文治,余宇峰.腹针治疗对膝关节骨性关节炎患者生存质量的影响[J],新中医,2007,39(2)：41-42.
[102]葛鸿庆,陈文治,余宇峰.腹针治疗膝关节骨性关节炎的临床疗效观察[J].四川中医,2006,24(12)：94-95.
[103]De BilE, Jonsson K, Reinholt FP, et al. Focaldestmction and remodeling in guinea pig arthrosis[J]. Acta Orthop Scand,1996,6(7):498-504.
[104]Ross JM, Sherwin AF, Poole CA. In vitro culture of enzymatically isolated chondmns:a possible model for the initiation of osteoarthrit[J]. J Anat, 2006,20(9):793-806.
[105]张洪,江捍平,王大平.关节制动制作骨性关节炎动物模型的探讨[J].中国现代医学杂志,2006,16(12)：1843-1848.
[106]石辉,何斌,史晨辉,等.用尿激酶型纤溶酶原激活物建立兔骨关节炎模型的 研究[J].石河子大学学报(自然科学版),2006,24(1)：66-69.
[107]KikuchiT, SakutaT, YamaguchiT. Intraarticular injection of collagenase induces experimental osteoarthritis in mature rabbits [J]. Osteoarthritis Cartilage。1998,6(3):177-186.
[108]胡阿威,张磊,张功礼.改良Hulth法骨关节炎动物模型的建立[J].中华医学丛刊.2003,9(3)：5.
[109]高益民.膝关节骨关节炎Ⅱ期临床试验方案[J].中药新药与临床药理,1998：9(1)：17-18.
[110]JH Kellgren and JS Lawrence. Radiological assessment of osteoarthritis.Ann Rheum Dis, Dec1957;16(4):494-502.
[111]郑筱英.中药新药临床研究指导原则[M].中国医药科技出版社出版,北京：2002,第一版.
[112]Insall J N, Ranawat CS, Aglietti P, et al. J Bone Joint Srug,1976,6A:754.
《黄帝内经》《伤寒杂病论》《说文解字》《中藏经》《易经通注》《内经博义》《诸病源侯论》《备急千金要方》《三因极一病证方论》《儒门事亲》《丹溪心法》《格致余论》《脾胃论》《妇人良方大全》《证治要决》《古今医鉴》《景岳全书》《傅青主男科》《医门法律》《临证指南医案》《医衡》《医碥》《顾松园医镜》《杂证会心录》《医学从众录》《温病条辨》《医林改错》《血证论》《友渔斋医话》《医学传心录》《岭南卫生方》《本草正义》《本草备要》《神农本草经》《本草逢原》《本草求真》《本草汇言》《名医别录》《本草纲目》《本经疏证》《药品化义》《本草新编》《开宅本草》《类证治裁》
[2]徐卫东,吴岳嵩,张春才.骨关节炎的诊断与治疗.第二军医大学出版社.
[3]张乃峥,施全胜,张雪哲,等.膝骨关节炎的流行病学调查[J].中华内科杂志.1995：34(2)：84-87.
[4]曾庆徐,黄小粥,陈韧,等.汕头地区风湿病流行病学调查十年小结[J].汕头大学医学院学报.1997：10(2)：59-63.
[5]张乃峥,曾庆徐,张风山,等.中国风湿性疾病流行情况的调查研究[J]中华风湿病学杂志.1997：1(1)：31-35.
[6]钱颐,孙凌云,王祝新,等.南京郊区农民症状性骨关节炎的流行病学调查明[J].江苏医药杂志2000：26(12)：967-968.
[7]臧长海,曾庆馀,李小峰,等.太原地区骨性关节炎流行病学研究[J].山西医药杂志,2006,35(9)：767-770.
[8]李宁华,张耀南,张毅,等.中国中老年人群手骨性关节炎患病危险因素地区比较分析[J].实用医学杂志,2006,22(13)：1575-1577.
[9]Sakeba N, Issa and Leena Sharma, et al. Epidemiology of osteoarthritis:An update[J]. Current Rheumatology Reports,2006.8(2):7-15.
[10]Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study[J]. Am J Public Health,1994;84:351-358.
[11]邱贵兴.骨性关炎流行病学和病因学新进展[J].继续医学教育,2005,19(7)：68-69.
[12]高仰贤,江蓉星.骨性关节炎发病机制的国内研究进展[J].中医正骨,2005,17(4)：55-57.
[13]Gabriel SE, Cmwson CS, OfaUon wM. The epidemiology of rheumatold arthritis in Rochester, Mirmesom,19S5—1985[J]. ArthritisRheum,1999,42(3): 415-420. Oliveria SA, CafreyM, Linden SM, etal. The anals of epidemiology about human arthritis[J], Epidemiology,2004,15:326-331.
[14]黄涛.骨性关节炎病因和发病机制研究进展[J].福建中医药,2005,36(4)：57.
[15]Grazio S, Balen D. Obesity:risk factor and predictor of osteoarthritis [J]. Ann Intern Med,2009;109:18-24.
[16]Bijlsma JW, Knahr K. Strategies for the prevention and management of osteoarthritis of the hip and knee[J]. Best Pract Res Clin Rheumatol, 2007;21(1):59-76.
[17]Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framing—ham study[J]. Ann Intern Med,1992;116(7):535-539
[18]牛维.软骨下骨在骨性关节炎发病中的作用研究[J].国际骨科学杂志,2006,27(3)：132-13.
[19]Felson DT, Nevitt MC. The effects of estrogen on osteoarthritis [J]. Curr Opin Rheumatol,1998;10:269-272.
[20]Slemenda C, Heilman DK, Brandt KD, et al. Reduced quadriceps strength relative to body weight:a risk factor for knee osteoarthritis in womens [J] Arthritis Rheum,1998:41:1951-1959.
[21]Slemenda C, Brandt KD, Heilman D, et al. Quadriceps weakness and osteoarthritis of the knee[J]. Ann Intern Med,1997;127:97-104.
[22]关拮,卫四来.骨性关节炎病因探讨[J].吉林中医药,2009,29(3)：198-199.
[23]Apparailly F Verwaerde C, Jacquet C, etal. Adenovirus mediatedtransfer of viral IL.10 gene inhibits murine collagen. induced arthfi—tm[J]. J Immunol,1998,160(11):5213-5220.
[24]Raimund w Kinne, Thomas Liehr, Volkmar Beensen. et al. Mosaicchromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthfiti, osteoarthritis and other inflammatory joint disease[J]. Arthritis Res, 2001,3(5):319-330.
[25]王卫国,娄思权,余华,等.TGF-β2转染关节软骨细胞的实验研究[J].中华骨科杂志,2003,23：434.
[26]王玉泉,守敏,柴举龙.蛋白多糖与骨性关节炎的研究[J].中医正骨,2005,17(4)：60.
[27]栗占国.骨性关节炎的发病机制[J].中华全科医师杂志,2003.6(3)：50-51.
[28]Loeser RF. Aging and osteoarthritis:the role of chondrocyte senescence and aging changes in the cartilage matrix [J]. Osteoarthritis Cartilage, 2009 Mar 12. [Epub ahead of print].
[29]Price JS, Waters JG, Darrah C, et al. The role of chondrocyte senescence in osteoarthritis [J]. Aging Cell.2002.1 (1):57-65.
[30]Radin EL, Paul IL. Does cartilage compliance reduce skeletal impact loads? The relative force-attenuating properties of articular cartilage, synovial fluid, periarticular soft tissues and bone. Arthritis Rheum, 1970:13:139-144.
[31]娄思权.软骨修复和重建基础研究的现状.当代医学,2001,735.
[32]Pfander D, Heinz N, Rothe P, et al. Ann Rhenm Dis,2004; 63(3):240-244.
[33]Gebauer M, Saas J, Haag J, et al. Arthritis Res mler,2005; 7(2):R274-R284.
[34]Fan Z, Bau B, Yang H, et al. Arthritis Rheum,2005; 52(1):136-143.
[35]Chevalier X, Giraudeau B. Conrozier T, et al. J Rh eumatl,2005; 32(7): 1317-1323.
[36]田华,娄思权,党耕町等.肿瘤坏死因子-a导致软骨损伤的机制探讨.中华外科杂志.2000,38：76.
[37]程爱新,韩文玲,马大龙等.趋化素样因子1(CKLF1)对关节软骨细胞增殖及代谢的影响.北京大学学报(医学版),2003,35：399.
[38]Barrey Halliwell. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis,1995; 54:505-510.
[39]Little CB, Flannery CR, Hughes CE, et al. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration [J]. Osteoarthritis and Cartilage,2005,13(2):162-170.
[40]田华,党耕町,娄思权等.基质金属蛋白酶及其抑制剂在软骨细胞中的表达及其意义[J].北京医科大学学报,1999：31：189.
[41]郭常安,陈峥蝾,张秀荣.骨性关节炎基质金属蛋白酶1、2、3及其抑制物的表达与软骨退变的关系[J].复旦学报(医学版),2002;29：244.
[42]何永清.骨内高压与退行性膝关节病关系的临床研究[J].中国骨伤,1999,11(6)：3-4.
[43]Amoldi cc, Lemperg ILK, Linderbolm H. Intraosscous hypertension and paininthekne[J], J Bone Joint SurgBr.1975,57(3):360.
[44]许学猛,王羽丰,邓晋丰,等.补肾活血胶囊影响兔膝关节退变性疾病骨内压变化的实验研究[J].中国中医骨伤科杂志,2001,91(4)：24.
[45]毛宾尧,刘洪涛.胫、股骨内压与膝关节疼痛关系的研究和治疗方法探讨[J].骨与关节损伤杂志,1992;7(4)：206.
[46]金伟,陈廖斌.生物自由基与骨性关节炎[J].湖北预防医学杂志,2002;13：13
[47]孙材江,王惠,杨锡兰,等.退行性膝关节炎患者氧自由基代谢的观察.中华骨科杂志,1992：12(6)：433-435.
[48]Bukhardt H Schwingel M Mcmninter H et al Oxgen cadicals as effectors of cartilage destruction Arthritis Rheum 1086(89).379.
[49]李松,曹峻岭.自由基对体外培养人胚关节软骨细胞的影响.中华骨科杂志, 1998：18(7)：426-428.
[50]刘淑芳,李莹辉,徐团才.骨性关节炎的生化及病理变化.中国临床康复,2004：8(5)：938-939.
[51]Johnston SA, Fox SM. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. J Am Vet Med Assoc.1997 15;210(10):1486-92.
[52]高春阳.一氧化氮在骨性关节炎发病机制中的作用.国外医学免疫学分册,2001,24(3)：159.
[53]Pelletier JP. Pathophysiological targets in OA therapy [J]. osteoarthritis Cartilage,1999.7(3):353-4.
[54]Blanco FJ, Lotz M. IL-1 induced nitric oxideide inhibits chondrocyte proliferation via PEGZ, Exp Cell Res,1995,318:31.
[55]Hauselmann HJ, Evans CH, Michel BA,et al. Differencesin nitricoxide product by superficial and deep human articular chondrocyte s:implications for proteogly canturnoxer in inflammatory joint diseased. Jimmunol,1998,160:1444.
[56]Cao M, Westerhausen-Larson A, Niyibizi C, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. [J]. Biochem J,1997,324:305-310.
[57]Heraud F, Heraud A, Harmand M F. Apoptosis in normal and Osteoarthritic human artlcular cartilage. Ann Rheum Dis,2000,59:959.
[58]蔡伟平,汤亭亭骨关节炎的细胞生物学研究进展.国外医学.骨科分册,2004,25：18.
[59]程爱新,王莺,马大龙等.程序化死亡基因5 (PDCD5)在骨关节炎软骨细胞中的表达及意义.北京大学学报(医学版),2003,35：481.
[60]Aixin Cheng, Siquan Lou. Haowei Zhou. et al. Expression of PDCD5, a novel apoptosis related protein, in human osteoarthritic cartilage. Acta Pharrnacol Sin,2004,25:685.
[61]Mazzuca SA, Brandt KD, Katz BPC, et al. Effeccts of self-care education on the health status of inner-city patients with osteoarthritis of the knee. Arthritis rheum,1997;40:1446-1474.
[62]Felson DT, Anderson JJ, Naimark A, et al. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med,1998:109:18-24.
[63]野战涛,张卫平.关节骨性关节炎的治疗进展.临床误诊误治,2010,3(8)：783-786.
[64]陈景藻.现代物理治疗学.北京：人民军医出版社,2001.
[65]李晶,顾新,李艳,等.老年病物理治疗的经验和体会.中华理疗杂志,1999：22：218-220.
[66]Thamsborg G, Florescu A, Oturai P, et al. Treatment of knee osteoarthritis with pulsed electromagnetic fields:randomized, double-blind, placebo-controlled study [J]. Osteoarthritis-Cartilage,2005,13(7):575-581.
[67]Brandt KD, Bradley JD Should the initial drug used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug[J]. J Rheumatol,2001.28: 467-473
[68]Courtney P, Doherty M. Key questions concerning paracetamol and NSAIDs for osteoarthriltis[J]. Ann Rheum Dis,2002,61(9):767-773.
[69]Bombardier C, Laine L, Reiein A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis [J]. N Engl J Med,2000,343(21):1520-1528.
[70]崔长胜.玻璃酸钠关节腔内注射治疗骨关节炎的疗效观察[J].吉林医学,2008.17(29)：1460.
[71]李海萍,王秀敏,吴祖军,等.注射用玻璃酸钠治疗膝关节骨性关节炎[J].中国实用医药,2008,25(3)：101.
[72]张敬中,张维斌,任国忠,等.膝骨性关节炎关节内药物注射的疗效比较[J].辽宁中医药大学学报,2008：9：116-117.
[73]McCarty M F, Russell A L, Seed M P. Sulfated glycosaminoglycans and glucosamine may synergize in promoting synovial hyaluronic acid synthesis[J]. Med Hypotheses 2000,54(5):798-802.
[74]Omata T, Itokazu Y, Inoue N, et al. Effects of chondroitinsulfate-C on articular cartilage destruction in murine collagen induced arthritis [J]. ArznejmjttelfOrschung,2000,50(2):148-153.
[75]Monfort J, Nacher M, Montell E, et al. Chondroitin sulfate and hyaluronic acid (500-730 kda) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes[J]. Drugs Exp Clin Res,2005,31(2):71-76.
[76]芮云峰,张晓玲,王友.骨关节炎治疗相关基因研究进展[J].国际骨科学杂志,2007,28(2)：77-80.
[77]Chevalier X, Giraudeau B, Conrozier T, et al. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis:a multicenter study[J]. J Rheumatol,2005,32(7): 1317-1323.
[78]Chevalier X, Goupille P, Beaulieu A D, et al. Intraarticular injection of anakinra in osteoarthritis of the knee:Amulticenter, randomized, double-blind, placebo-controlled study[J]. Arthritis Rheum,2009,61(3): 344-352
[79]JACKSON J P. Osteotomy for arthritis of the knee[J]. J Bone andjoint Surg(Br),1958,40:826-836.
[80]Insall JN, Joseph DM, Msika C. Hi gh tibial osteotomy for varus gonarthrosis. A long-term follow-up study [J]. J Bone Joint Surg Am,1984, 66(7):1040-1048.
[81]曹立峰,裴宪武,李延明,等.改良胫骨高位截骨术治疗膝骨性关节炎32例报告[J].北京医学,2008,30(3)：187-188.
[82]张光铂,曹永廉,李子荣.胫骨高位截骨术的远期疗效[J].中国骨科杂志,1997,17(12)：737-739.
[83]余文君.胫骨高位钻孔减压后推拿治疗膝关节骨性关节病32例.广西中医药,2001：(2)：009.
[84]林志雄,余楠生,卢伟杰.关节镜诊断和治疗膝关节骨关节炎[J].中华骨科杂志,1998,18(4)：199-202.
[85]张卫平,刘长安,钱宇航,等.膝关节镜下治疗髌股关节退行性变的方法探讨[J].中国矫形外科杂志,2004,12(12)：28-29.
[86]Moseley J B,0 Malley K, Petersen N J, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee[J]. N Engl J Med, 2002,347(2):81-88.
[87]Kirkley A, Birmingham T B, Litchfield R B, et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee[J]. N Engl J Med, 2008,359(11):1097-1107.
[88]赵炬才,罗建平,郑稼.带血管蒂筋膜移植修复膝关节软骨大面积缺损.中华骨科杂志,1996：16：479.
[89]Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage,2002, 10 (3):199-206.
[90]Petrou G, Petrou H, Tilkeridis C, et al. Medium-term results with a primary cemented rotating-hinge total knee replacement. A 7 to 15-year follow-up. J Bone Joint Surg Br.2004,86(6):813-817.
[91]Berger RA, Meneghini RM, Jacobs JJ, et al. Results of unicOmpartmental knee arthroplasty at a minimum of ten years of follow-up. J Bone Joint Surg Am,2005,87(5):999-1006.
[92]Callaghan JJ,0'Rourke MR, Johnston RC. The uni experience:history tells it all. Orthopedics,2005,28(9):988.
[93]Squire MW, Callaghan JJ, Goetz DD, et al. Unicompartmental knee replacement. A minimum 15 year follow up study. Clin Orthop Relat Res, 1999(367):61-72.
[94]Newman J, Pydisetty RV, Ackroyd C. Unicompartmental or total knee replacement:the 15-year results of a prospective randomized controlled trail. J Bone J Joint Br,2009,91(1):52-57.
[95]Riddle DL, J iranekWA, McGlynn FJ. Yearly incidence of unieompartmental knee arthroplasty in the United States. J Arthroplasty,2008,23(3): 408-412.
[96]甘煜东,丁晶,徐永清等.膝关节单髁置换的近期疗效观察.中国骨与关节外科,2010,3(4)：291-295.
[97]Murray JR, Birdsall PD, Sher JL, et al. Deprivation and outcome oftotal knee replacement[J]. Knee,2006,13(2):98-101.
[98]赵钟文.从补肾人手缓解膝关节骨性关节炎疼痛60例疗效观察[J].云南中医中药杂志,2005,26(6)：10.
[99]季守贤,包洪,康英.补肾壮骨汤治疗膝关节骨性关节炎42例[J].四川中医,2005,23(12)：82.
[100]薄智云主编.腹针疗法.北京,中国科学技术出版社,2004.129-130
[101]葛鸿庆,陈文治,余宇峰.腹针治疗对膝关节骨性关节炎患者生存质量的影响[J],新中医,2007,39(2)：41-42.
[102]葛鸿庆,陈文治,余宇峰.腹针治疗膝关节骨性关节炎的临床疗效观察[J].四川中医,2006,24(12)：94-95.
[103]De BilE, Jonsson K, Reinholt FP, et al. Focaldestmction and remodeling in guinea pig arthrosis[J]. Acta Orthop Scand,1996,6(7):498-504.
[104]Ross JM, Sherwin AF, Poole CA. In vitro culture of enzymatically isolated chondmns:a possible model for the initiation of osteoarthrit[J]. J Anat, 2006,20(9):793-806.
[105]张洪,江捍平,王大平.关节制动制作骨性关节炎动物模型的探讨[J].中国现代医学杂志,2006,16(12)：1843-1848.
[106]石辉,何斌,史晨辉,等.用尿激酶型纤溶酶原激活物建立兔骨关节炎模型的 研究[J].石河子大学学报(自然科学版),2006,24(1)：66-69.
[107]KikuchiT, SakutaT, YamaguchiT. Intraarticular injection of collagenase induces experimental osteoarthritis in mature rabbits [J]. Osteoarthritis Cartilage。1998,6(3):177-186.
[108]胡阿威,张磊,张功礼.改良Hulth法骨关节炎动物模型的建立[J].中华医学丛刊.2003,9(3)：5.
[109]高益民.膝关节骨关节炎Ⅱ期临床试验方案[J].中药新药与临床药理,1998：9(1)：17-18.
[110]JH Kellgren and JS Lawrence. Radiological assessment of osteoarthritis.Ann Rheum Dis, Dec1957;16(4):494-502.
[111]郑筱英.中药新药临床研究指导原则[M].中国医药科技出版社出版,北京：2002,第一版.
[112]Insall J N, Ranawat CS, Aglietti P, et al. J Bone Joint Srug,1976,6A:754.
《黄帝内经》《伤寒杂病论》《说文解字》《中藏经》《易经通注》《内经博义》《诸病源侯论》《备急千金要方》《三因极一病证方论》《儒门事亲》《丹溪心法》《格致余论》《脾胃论》《妇人良方大全》《证治要决》《古今医鉴》《景岳全书》《傅青主男科》《医门法律》《临证指南医案》《医衡》《医碥》《顾松园医镜》《杂证会心录》《医学从众录》《温病条辨》《医林改错》《血证论》《友渔斋医话》《医学传心录》《岭南卫生方》《本草正义》《本草备要》《神农本草经》《本草逢原》《本草求真》《本草汇言》《名医别录》《本草纲目》《本经疏证》《药品化义》《本草新编》《开宅本草》《类证治裁》